SANM vs. GMAB
SANM (Sanmina Corporation) and GMAB (Genmab A/S) are both stocks. SANM operates in Electronic Components (Technology), while GMAB operates in Biotechnology (Healthcare). Over the past 10 years, SANM returned 25.08%/yr vs 4.58%/yr for GMAB. At a 0.13 correlation, their price movements are largely independent.
Performance
SANM vs. GMAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SANM achieves a 64.62% return, which is significantly higher than GMAB's -15.78% return. Over the past 10 years, SANM has outperformed GMAB with an annualized return of 25.08%, while GMAB has yielded a comparatively lower 4.58% annualized return.
SANM
- 1D
- -2.53%
- 1M
- 0.24%
- YTD
- 64.62%
- 6M
- 60.24%
- 1Y
- 169.37%
- 3Y*
- 63.22%
- 5Y*
- 44.58%
- 10Y*
- 25.08%
GMAB
- 1D
- 1.29%
- 1M
- -3.46%
- YTD
- -15.78%
- 6M
- -22.91%
- 1Y
- 25.44%
- 3Y*
- -12.24%
- 5Y*
- -9.17%
- 10Y*
- 4.58%
SANM vs. GMAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SANM Sanmina Corporation | 64.62% | 98.32% | 47.30% | -10.33% | 38.18% | 30.01% | -6.86% | 42.31% | -27.09% | -9.96% |
GMAB Genmab A/S | -15.78% | 47.58% | -34.45% | -24.87% | 7.13% | -2.71% | 82.09% | 35.54% | -0.61% | -0.04% |
Correlation
The correlation between SANM and GMAB is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2009 | 0.13 |
Fundamentals
SANM:
$13.66B
GMAB:
$16.56B
SANM:
$4.72
GMAB:
$4.10
SANM:
52.29
GMAB:
6.33
SANM:
10.20
GMAB:
0.42
SANM:
1.20
GMAB:
1.87
SANM:
1.94
GMAB:
2.92
SANM:
$11.34B
GMAB:
$8.84B
SANM:
$968.36M
GMAB:
$8.27B
SANM:
$365.81M
GMAB:
$3.81B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SANM vs. GMAB — Risk / Return Rank
SANM
GMAB
SANM vs. GMAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanmina Corporation (SANM) and Genmab A/S (GMAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SANM | GMAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.75 | ||
| Sortino ratioReturn per unit of downside risk | +1.70 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.15 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 5.21 | 0.79 | +4.43 |
| Martin ratioReturn relative to average drawdown | 12.88 | 1.67 | +11.22 |
Loading charts...
Drawdowns
SANM vs. GMAB - Drawdown Comparison
The maximum SANM drawdown since its inception was -99.66%, which is greater than GMAB's maximum drawdown of -84.20%. Use the drawdown chart below to compare losses from any high point for SANM and GMAB.
Loading charts...
Drawdown Indicators
| SANM | GMAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.66% | -84.20% | -15.46% |
Max Drawdown (1Y)Largest decline over 1 year | -32.69% | -32.51% | -0.18% |
Max Drawdown (3Y)Largest decline over 3 years | -32.69% | -57.44% | +24.75% |
Max Drawdown (5Y)Largest decline over 5 years | -33.92% | -63.10% | +29.18% |
Max Drawdown (10Y)Largest decline over 10 years | -55.85% | -63.10% | +7.25% |
Current DrawdownCurrent decline from peak | -30.21% | -46.76% | +16.55% |
Average DrawdownAverage peak-to-trough decline | -71.39% | -31.11% | -40.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.20% | 15.28% | -2.08% |
Volatility
SANM vs. GMAB - Volatility Comparison
Sanmina Corporation (SANM) has a higher volatility of 19.07% compared to Genmab A/S (GMAB) at 10.81%. This indicates that SANM's price experiences larger fluctuations and is considered to be riskier than GMAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SANM | GMAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.07% | 10.81% | +8.26% |
Volatility (6M)Calculated over the trailing 6-month period | 49.01% | 25.42% | +23.59% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.39% | 34.26% | +34.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.60% | 33.47% | +11.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 42.09% | 35.02% | +7.07% |
Dividends
SANM vs. GMAB - Dividend Comparison
Neither SANM nor GMAB has paid dividends to shareholders.
Financials
SANM vs. GMAB - Financials Comparison
This section allows you to compare key financial metrics between Sanmina Corporation and Genmab A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SANM vs. GMAB - Profitability Comparison
SANM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanmina Corporation reported a gross profit of 354.98M and revenue of 4.01B. Therefore, the gross margin over that period was 8.9%.
GMAB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a gross profit of 834.08M and revenue of 899.32M. Therefore, the gross margin over that period was 92.8%.
SANM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanmina Corporation reported an operating income of 157.01M and revenue of 4.01B, resulting in an operating margin of 3.9%.
GMAB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported an operating income of 225.83M and revenue of 899.32M, resulting in an operating margin of 25.1%.
SANM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanmina Corporation reported a net income of 93.65M and revenue of 4.01B, resulting in a net margin of 2.3%.
GMAB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Genmab A/S reported a net income of 53.20M and revenue of 899.32M, resulting in a net margin of 5.9%.
Frequently Asked Questions
SANM and GMAB have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SANM has higher volatility (19.07%) compared to GMAB (10.81%). In terms of maximum drawdown, SANM dropped -99.66% vs GMAB's -84.20%.
SANM currently has the higher Sharpe Ratio (2.49 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SANM and GMAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer